Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Integrating cheminformatic analysis in combinatorial chemistry.

James F Blake1

  • 1Array BioPharma Inc., 3200 Walnut Street, Boulder, Colorado 80301, USA. jim.blake@arraybiopharma.com

Current Opinion in Chemical Biology
|August 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of 5-Azaquinoxaline Derivatives as Potent and Orally Bioavailable Allosteric SHP2 Inhibitors.

ACS medicinal chemistry letters·2023
Same author

Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS<sup>G12D</sup> Inhibitor.

Journal of medicinal chemistry·2021
Same author

Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer.

JCO precision oncology·2020
Same author

Identification of the Clinical Development Candidate <b>MRTX849</b>, a Covalent KRAS<sup>G12C</sup> Inhibitor for the Treatment of Cancer.

Journal of medicinal chemistry·2020
Same author

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2020
Same author

Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity.

ACS medicinal chemistry letters·2019
Same journal

Function through shape: An overview of DNA G-quadruplexes in transcriptional regulation.

Current opinion in chemical biology·2026
Same journal

Advances in tools and technologies for multiplexed bioluminescence imaging.

Current opinion in chemical biology·2026
Same journal

High-resolution molecular mapping by expansion-coupled label-free and multimodal imaging.

Current opinion in chemical biology·2026
Same journal

Recent advances in glycoconjugate-based therapeutics.

Current opinion in chemical biology·2026
Same journal

Towards better red emitters for bioimaging: Innovations in rhodamine and cyanine chemistry.

Current opinion in chemical biology·2026
Same journal

Chemigenetic fluorescent biosensors in biological imaging - New trends and advances.

Current opinion in chemical biology·2026
See all related articles

Cheminformatics analysis identified key physicochemical properties for drug-like compounds. This knowledge aids in building better combinatorial libraries and improving compound selection strategies.

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Drug Discovery

Background:

  • Drug discovery relies on identifying compounds with favorable drug-like properties.
  • Combinatorial libraries are crucial for generating diverse compound collections.
  • Optimizing library construction is essential for efficient drug development.

Purpose of the Study:

  • To identify critical physicochemical properties influencing drug-likeness using cheminformatics.
  • To define parameters for constructing high-quality combinatorial libraries.
  • To explore techniques for enhancing compound selection in library design.

Main Methods:

  • Cheminformatic analysis of drug-related compound databases.
  • Identification and evaluation of physicochemical property influences.

Related Experiment Videos

  • Development of strategies for combinatorial library construction.

    • Main Results:

    • Key physicochemical properties significantly impacting drug-like characteristics were identified.
    • Parameters and profiles for high-quality combinatorial library construction were defined.
    • Techniques to improve the inclusion of optimal compounds in libraries were highlighted.

    Conclusions:

    • Cheminformatics provides valuable insights into drug-like properties.
    • Defined parameters enhance the quality and efficiency of combinatorial library design.
    • Advanced techniques increase the probability of discovering superior drug candidates.